IGMS

IGM Biosciences
IGMS

Overview Fund Activity
Delisted

IGMS was delisted on the 13th of August, 2025.

Back to rankings

82 hedge funds and large institutions have $305M invested in IGM Biosciences in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 15 closing their positions.

Holders
82
Holders Change
-10
Holders Change %
-10.87%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
36
Reduced
23
Closed
15
Calls
$1.07M
Puts
$165K
Net Calls
+$903K
Net Calls Change
+$37K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$11.8M
2
CS
2
Candriam SCA
Luxembourg
$2.7M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.58M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$9.82M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$6.63M

Top Sellers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$0
2
Alkeon Capital Management
2
Alkeon Capital Management
New York
$14.2M
3
Voloridge Investment Management
3
Voloridge Investment Management
Florida
$0
4
Goldman Sachs
4
Goldman Sachs
New York
$3.38M
5
WP
5
Woodline Partners
California
$2.55M
Name Holding Trade Value Shares
Change 		Shares
Change %
RG
1
Redmile Group
California
$56.7M – – –
BBA
2
Baker Bros. Advisors
New York
$53.7M – – –
AG
3
Artal Group
Luxembourg
$41.7M – – –
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$37.5M -$193K -11,359 -0.5%
Alkeon Capital Management
5
Alkeon Capital Management
New York
$14.2M -$2.18M -128,372 -13%
BlackRock
6
BlackRock
New York
$13.4M +$839K +49,303 +7%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$11.8M +$11.7M +690,429 +130,516%
Vanguard Group
8
Vanguard Group
Pennsylvania
$9.82M +$973K +57,190 +11%
UBS AM
9
UBS AM
Illinois
$8.24M -$674K -39,612 -8%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$6.63M +$897K +52,716 +16%
Millennium Management
11
Millennium Management
New York
$5.68M +$731K +42,970 +15%
Marshall Wace
12
Marshall Wace
United Kingdom
$4.89M +$693K +40,739 +17%
State Street
13
State Street
Massachusetts
$3.85M +$71.5K +4,205 +2%
Goldman Sachs
14
Goldman Sachs
New York
$3.38M -$856K -50,343 -20%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$3.3M +$183K +10,735 +6%
CS
16
Candriam SCA
Luxembourg
$2.7M +$1.87M +110,225 +226%
SB
17
Samsara BioCapital
California
$2.63M – – –
WP
18
Woodline Partners
California
$2.55M -$851K -50,047 -25%
Northern Trust
19
Northern Trust
Illinois
$2.04M +$109K +6,399 +6%
Renaissance Technologies
20
Renaissance Technologies
New York
$1.58M +$1.36M +80,200 +637%
Morgan Stanley
21
Morgan Stanley
New York
$1.56M -$140K -8,256 -8%
Victory Capital Management
22
Victory Capital Management
Texas
$1.53M +$166K +9,750 +12%
Nuveen Asset Management
23
Nuveen Asset Management
Illinois
$1.41M +$645K +37,920 +84%
Charles Schwab
24
Charles Schwab
California
$1.21M +$21.3K +1,250 +2%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$1.14M +$13.4K +787 +1%
1
2 3 4